Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 22 of 79

  1. The brain is a common site for metastasis in non-small-cell lung cancer (NSCLC). This study was designed to evaluate the relationship between the mutational of the epidermal growth factor receptor (EGFR) and o...

    Authors: Wen-Ya Li, Ting-Ting Zhao, Hui-Mian Xu, Zhen-Ning Wang, Ying-Ying Xu, Yunan Han, Yong-Xi Song, Jian-Hua Wu, Hao Xu, Song-Cheng Yin, Xing-Yu Liu and Zhi-Feng Miao
    Citation: BMC Cancer 2019 19:145
  2. Prenylated Rab acceptor 1 domain family, member 2 (PRAF2) is involved in the occurrence and progression of several malignant tumors. However, its potential role in esophageal squamous cell carcinoma (ESCC) is ...

    Authors: Zhaoye Qian, Bin Wei, Yu Zhou, Qiuzi Wang, Jiru Wang, Yuan Sun, Yong Gao and Xiaofei Chen
    Citation: BMC Cancer 2019 19:585
  3. Predicting short-term efficacy and intracranial progression-free survival (iPFS) in epidermal growth factor receptor gene mutated (EGFR-mutated) lung adenocarcinoma patients with brain metastases who receive t...

    Authors: Haoran Qi, Yichen Hou, Zhonghang Zheng, Mei Zheng, Qiang Qiao, Zihao Wang, Xiaorong Sun and Ligang Xing
    Citation: BMC Cancer 2024 24:362
  4. The ubiquity-proteasome system is an indispensable mechanism for regulating intracellular protein degradation, thereby affecting human antigen processing, signal transduction, and cell cycle regulation. We use...

    Authors: Xiao Li, Xinru Li, Yuexin Hu, Ouxuan Liu, Yuxuan Wang, Siting Li, Qing Yang and Bei Lin
    Citation: BMC Cancer 2023 23:573
  5. Nearly 30% of clear cell renal cell carcinoma (ccRCC) patients present with metastasis at the time of diagnosis, and the prognosis for these patients is poor. Therefore, novel potential prognostic biomarkers a...

    Authors: Yi Xu, Yanyue Tong, Jianyong Zhu, Zhangming Lei, Lijun Wan, Xiuwen Zhu, Feng Ye and Liping Xie
    Citation: BMC Cancer 2017 17:373
  6. Despite smoking cessation can largely improve cancer prognosis and quality of life, many patients continued smoking after the diagnosis of cancer. This study aims to test the effectiveness of a smoking cessati...

    Authors: William H.C. Li, Sophia S.C. Chan, Kelvin M. P. Wang and T.H. Lam
    Citation: BMC Cancer 2015 15:490
  7. Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies and is not a clinically homogeneous disease, but subsets of patients with distinct prognosis and response to therapy can be identi...

    Authors: Maria Cristina Curia, Fabiana Fantini, Rossano Lattanzio, Francesca Tavano, Francesco Di Mola, Mauro Piantelli, Pasquale Battista, Pierluigi Di Sebastiano and Alessandro Cama
    Citation: BMC Cancer 2019 19:452
  8. Radioimmunotherapy with cetuximab and conjugates with various radioisotopes is a feasible treatment option for different tumor models. Scandium-47 (47Sc), one of several β−-particle-emitting radioisotopes, displa...

    Authors: Da-Mi Kim, So-Young Lee, Jae-Cheong Lim, Eun-Ha Cho and Ul-Jae Park
    Citation: BMC Cancer 2023 23:652
  9. Cancer, heart failure and stroke are among the most common causes of death worldwide. Investigation of the prognostic impact of each disease is important, especially for a better understanding of competing ris...

    Authors: Vasileios Askoxylakis, Christian Thieke, Sven T Pleger, Patrick Most, Judith Tanner, Katja Lindel, Hugo A Katus, Jürgen Debus and Marc Bischof
    Citation: BMC Cancer 2010 10:105
  10. Pancreatic cancer (PC) is a highly malignant tumor featured with high intra-tumoral heterogeneity and poor prognosis. Cell-in-cell (CIC) structures have been reported in multiple cancers, and their presence is...

    Authors: Jianlu Song, Rexiati Ruze, Yuan Chen, Ruiyuan Xu, Xinpeng Yin, Chengcheng Wang, Qiang Xu and Yupei Zhao
    Citation: BMC Cancer 2022 22:894
  11. Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome. Comparison of prognosis between LS and sporadic CRC (SCRC) were rare, with conflicting results. This study aimed to compare t...

    Authors: Yun Xu, Cong Li, Charlie Zhi-Lin Zheng, Yu-Qin Zhang, Tian-An Guo, Fang-Qi Liu and Ye Xu
    Citation: BMC Cancer 2021 21:45
  12. Breast cancer (BC) is the second-leading factor of mortality for women globally and is brought on by a variety of genetic and environmental causes. The conventional treatments for this disease have limitations...

    Authors: Ying Jiang, Jiayu Liu, Lingyan Chen, Zhiwen Qian and Yan Zhang
    Citation: BMC Cancer 2024 24:182
  13. Published findings suggest sex differences in lung cancer risk and a potential role for sex steroid hormones. Our aim was to perform a meta-analysis to investigate the effects of sex steroid hormone exposure s...

    Authors: Hui Zeng, Zhuoyu Yang, Jiang Li, Yan Wen, Zheng Wu, Yadi Zheng, Yiwen Yu, Yongjie Xu, Shugeng Gao, Fengwei Tan, Ni Li, Qi Xue and Jie He
    Citation: BMC Cancer 2021 21:690
  14. High levels of circulating C-reactive protein (CRP) have recently been linked to poor clinical outcome in various malignancies. The aim of this study was to evaluate the prognostic significance of the preopera...

    Authors: Sandra Steffens, Andreas Al Ghazal, Julie Steinestel, Rieke Lehmann, Gerd Wegener, Thomas J Schnoeller, Marcus V Cronauer, Florian Jentzmik, Mark Schrader, Markus A Kuczyk and Andres J Schrader
    Citation: BMC Cancer 2013 13:223
  15. Osteosarcoma is the most common primary malignant bone tumor. The current study was conducted to describe the general condition of patients with primary osteosarcoma in a single cancer center in Tianjin, China...

    Authors: Chao Zhang, Haixiao Wu, Guijun Xu, Yao Xu, Wenjuan Ma, Zhijun Li and Jin Zhang
    Citation: BMC Cancer 2023 23:506
  16. The role of the chemokine CCL2 in breast cancer is controversial. While CCL2 recruits and activates pro-tumor macrophages, it is also reported to enhance neutrophil-mediated anti-tumor activity. Moreover, loss...

    Authors: Nicole Lavender, Jinming Yang, Sheau-Chiann Chen, Jiqing Sai, C. Andrew Johnson, Philip Owens, Gregory D. Ayers and Ann Richmond
    Citation: BMC Cancer 2017 17:88
  17. Peri-operative chemo-radiotherapyplayed important rolein locally advanced gastric cancer. Whether preoperative strategy can improve the long-term prognosis compared with postoperative treatment is unclear. The...

    Authors: Ning Li, Xiaoyong Xiang, Dongbin Zhao, Xin Wang, Yuan Tang, Yihebali Chi, Lin Yang, Liming Jiang, Jun Jiang, Jinming Shi, Wenyang Liu, Hui Fang, Yu Tang, Bo Chen, Ningning Lu, Hao Jing…
    Citation: BMC Cancer 2022 22:212
  18. The preoperative peripheral blood neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and monocyte-lymphocyte ratio (MLR) have been reported to be associated with the prognosis of various cancer...

    Authors: Rong Cong, Fanfei Kong, Jian Ma, Qing Li, Qijun Wu and Xiaoxin Ma
    Citation: BMC Cancer 2020 20:464
  19. Many studies have explored the cost-effectiveness of immunotherapy versus chemotherapy alone. However, there is paucity of evidence on direct pharmacoeconomic studies related to immunotherapy combinations. Thu...

    Authors: Wen Hui, Ruomeng Song, Hongyu Tao, Zhixiang Gao, Min Zhu, Mingyue Zhang, Huazhang Wu, Daichen Gong, Xiyan Zhang and Yuanyi Cai
    Citation: BMC Cancer 2023 23:442
  20. This study explores and analyzes the clinical characteristics and prognostic factors of hepatoblastoma (HB) in children under 6 years old and establishes a new risk-stratification system for individualized the...

    Authors: Tian Zhi, Wei-Ling Zhang, Yi Zhang, Hui-Min Hu, Yi-Zhuo Wang and Dong-Sheng Huang
    Citation: BMC Cancer 2021 21:397
  21. The residual cancer burden index (RCB) was proposed as a response evaluation criterion in breast cancer patients treated with Neoadjuvant Chemotherapy (NAC). This study evaluated the relevance of RCB with repl...

    Authors: Xin Xu, Wei Zhao, Cuicui Liu, Yongsheng Gao, Dawei Chen, Meng Wu, Chao Li, Xinzhao Wang, Xiang Song, Jinming Yu, Zhaoyun Liu and Zhiyong Yu
    Citation: BMC Cancer 2024 24:13
  22. Pyroptosis is a newly discovered form of cell programmed necrosis, but its role and mechanism in cancer cells remain unclear. The aim of this study is to systematically analyze the transcriptional sequencing d...

    Authors: Mingkai Gong, Xiangping Liu, Xian Zhao and Haibo Wang
    Citation: BMC Cancer 2022 22:1005
  23. The origin recognition complex (ORC), a six-subunit DNA-binding complex, participates in DNA replication in cancer cells. Specifically in prostate cancers, ORC participates the androgen receptor (AR) regulated...

    Authors: Yuan Lin, Ying Zhang, Zhouting Tuo, Liang Gao, Demao Ding, Liangkuan Bi, Dexin Yu, Zhengmei Lv, Jiani Wang and Xin Chen
    Citation: BMC Cancer 2023 23:285
  24. Increased collagen deposition provides physical and biochemical signals to support tumor growth and invasion during breast cancer development. Therefore, inhibition of collagen synthesis and deposition has bee...

    Authors: Gaofeng Xiong, Lei Deng, Jieqing Zhu, Piotr G Rychahou and Ren Xu
    Citation: BMC Cancer 2014 14:1
  25. The purpose of this study was to develop a functional clinical nomogram for predicting 8-year overall survival (OS) of patients with prostate cancer (PCa) primary based on peripheral lymphocyte.

    Authors: Jiayi Chen, Feng Yu, Ganyuan He, Wenke Hao and Wenxue Hu
    Citation: BMC Cancer 2024 24:254
  26. Dysregulation of long non-coding RNAs (lncRNAs) has been identified in ovarian cancer. However, the expression and biological functions of LINC00852 in ovarian cancer are not understood.

    Authors: Zhi-wei Qiao, Ying Jiang, Ling Wang, Lei Wang, Jing Jiang, Jing-ru Zhang and Peng Mu
    Citation: BMC Cancer 2021 21:1004
  27. The survival benefit of adjuvant transarterial chemoembolization (TACE) in patients with hepatectomy for hepatocellular carcinoma (HCC) after hepatectomy remains controversial. We aimed to investigate the surv...

    Authors: Zhao Wu, Lifeng Cui, Junlin Qian, Laihui Luo, Shuju Tu, Fei Cheng, Lebin Yuan, WenJian Zhang, Wei Lin, Hongtao Tang, Xiaodong Li, Hui Li, Yang Zhang, Jisheng Zhu, Yong Li, Yuanpeng Xiong…
    Citation: BMC Cancer 2023 23:325
  28. The full-length BRCA1-associated RING domain 1 (BARD1) gene encodes a 777-aa protein. BARD1 displays a dual role in cancer development and progression as it acts as a tumor suppressor and an oncogene. Structur...

    Authors: Yousef M. Hawsawi, Anwar Shams, Abdulrahman Theyab, Wed A. Abdali, Nahed A. Hussien, Hanan E. Alatwi, Othman R. Alzahrani, Atif Abdulwahab A. Oyouni, Ahmad O. Babalghith and Mousa Alreshidi
    Citation: BMC Cancer 2022 22:599
  29. Excision repair cross-complementation group 6 like (ERCC6L), a polo-like kinase 1 (PLK1)-interacting checkpoint helicase, confers a high risk of cancer and enhances the progression of a variety of cancers. The...

    Authors: Zhimin Lu, Lihong Fei and Guoxin Hou
    Citation: BMC Cancer 2022 22:1347
  30. Adequate surgery still remains the only curative treatment of chordoma. Interesting clinical data on advanced disease with molecularly targeted therapies were reported.

    Authors: Virginia Ferraresi, Carmen Nuzzo, Carmine Zoccali, Ferdinando Marandino, Antonello Vidiri, Nicola Salducca, Massimo Zeuli, Diana Giannarelli, Francesco Cognetti and Roberto Biagini
    Citation: BMC Cancer 2010 10:22
  31. The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing su...

    Authors: Li-Chu Sun, Koung-Shing Chu, Su-Chen Cheng, Chien-Yu Lu, Chao-Hung Kuo, Jan-Sing Hsieh, Ying-Ling Shih, Shun-Jen Chang and Jaw-Yuan Wang
    Citation: BMC Cancer 2009 9:288
  32. Cancer cells, stem cells and cancer stem cells have for a long time played a significant role in the biomedical sciences. Though cancer therapy is more effective than it was a few years ago, the truth is that ...

    Authors: Sara S. Franco, Karolina Szczesna, Maria S. Iliou, Mohammed Al-Qahtani, Ali Mobasheri, Julianna Kobolák and András Dinnyés
    Citation: BMC Cancer 2016 16(Suppl 2):738

    This article is part of a Supplement: Volume 16 Supplement 2

  33. ITPR1 is a key gene for autophagy, but its biological function is still unclear, and there are few studies on the correlation between ITPR1 gene expression and the occurrence and development of breast cancer.

    Authors: Bing Han, Fang Zhen, Xiu-Shuang Zheng, Jing Hu and Xue-Song Chen
    Citation: BMC Cancer 2022 22:297
  34. The nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) is a long non-coding RNA aberrantly expressed in human malignancies. We aimed to analyze available data to evaluate the correlation betwee...

    Authors: Chenghao Zhang, Xiaolei Ren, Zhongyue Liu and Chao Tu
    Citation: BMC Cancer 2020 20:879
  35. Surgery is still the mainstay of radical treatment for resectable esophageal cancer (EC). It is apparent that the presence or spread of lymph node metastasis (LNM) is a powerful prognostic factor in patients w...

    Authors: Yutaka Miyawaki, Hiroshi Sato, Shuichiro Oya, Hirofumi Sugita, Yasumitsu Hirano, Shinichi Sakuramoto, Kojun Okamotom, Shigeki Yamaguchim and Isamu Koyama
    Citation: BMC Cancer 2021 21:725
  36. Palliative surgery followed by postoperative chemotherapy is a challenging approach in the treatment of stage IV gastric cancer yet patients must be carefully selected on the basis of likely clinical benefit.

    Authors: John Syrios, Stavros Sougioultzis, Ioannis D Xynos, Nikolaos Kavantzas, Christos Kosmas, George Agrogiannis, John Griniatsos, Ioannis Karavokyros, Emmanouil Pikoulis, Efstratios S Patsouris and Nikolas Tsavaris
    Citation: BMC Cancer 2012 12:264
  37. HBV infection is the leading risk factor for HCC. HBV infection has been confirmed to be associated with the exhaustion status of CD8+ T cells and immunotherapeutic efficacy in HCC. In this study, we aimed to inv...

    Authors: Jianhao Li, Han Chen, Lang Bai and Hong Tang
    Citation: BMC Cancer 2024 24:53
  38. 5–10% of patients are diagnosed with metastatic breast cancer (MBC) at the initial diagnosis. This study aimed to develop a nomogram to predict the overall survival (OS) of these patients.

    Authors: Wen Zhao, Lei Wu, Andi Zhao, Mi Zhang, Qi Tian, Yanwei Shen, Fan Wang, Biyuan Wang, Le Wang, Ling Chen, Xiaoai Zhao, Danfeng Dong, Lingxiao Zhang and Jin Yang
    Citation: BMC Cancer 2020 20:982
  39. NEDD4 family represent an important group of E3 ligases, which regulate various cellular pathways of cell proliferation, cell junction and inflammation. Emerging evidence suggested that NEDD4 family members pa...

    Authors: Liangzi Cao, Hao Li, Xiaofang Liu, Yubang Wang, Bowen Zheng, Chengzhong Xing, Naijin Zhang and Jingwei Liu
    Citation: BMC Cancer 2023 23:526
  40. Fibrosis surrounding cancer cells has been shown to affect cancer cell metastatic behavior. The present study aimed to explore the utility of myxoid stroma as a predictive factor for postoperative relapse in p...

    Authors: Takashi Okuyama, Shinichi Sameshima, Emiko Takeshita, Takashi Mitsui, Takuji Noro, Yuko Ono, Tamaki Noie, Shinichi Ban and Masatoshi Oya
    Citation: BMC Cancer 2020 20:842
  41. To date, patients with metastasized pancreatic ductal adenocarcinoma (PDAC M1) are regarded as a uniform collective. We hypothesize the existence of oligometastatic disease (OMD): a state of PDAC M1 disease wi...

    Authors: Alexander I. Damanakis, Luisa Ostertag, Dirk Waldschmidt, Fabian Kütting, Alexander Quaas, Patrick Plum, Christiane J. Bruns, Florian Gebauer and Felix Popp
    Citation: BMC Cancer 2019 19:1261

Featured videos

View featured videos from across the BMC-series journals